Ahmadi A. Method of preparation of an antitumor herbal drug (HESA-A). Islamic Republic of Iran Patent 27741. 2002 (patent).

Ahmadi A, Naderi G, Asgary S. Evaluation of hepatoprotective potential of HESA-A (a marine compound) pretreatment against thioacetamide-induced hepatic damage in rabbits. Drugs Exp Clin Res 2005;31:1–6.

Fazly Bazzaz BS. HESA-A, its cytotoxicity and mutagenicity. J Oncol Pharm Pract 2006;12:60.

Sadeghi-Aliabadi H, Ahmadi A. Cytotoxicity and antitumor properties of a marine compound, HESA-A, on cancer cells. Daru 2003;11:82–87.

Ahmadi A. Analysis of HESA-A, report of Atomic Energy Organization of Iran (AEOI), Research Division, Tehran, Islamic Republic of Iran, 2004.

Zeng H, Combs GF Jr. Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem 2008;19:1–7.

Caruso F, Rossi M. Antitumor titanium compounds and related metallocenes. Miner Rev Med Chem 2004; 42:353–384.

Guo J, Deng W, Zhang L, Li C, Wu P, Mao P. Prediction of prostate cancer using hair trace element concentration and support vector machine method. Biol Trace Elem Res 2007;116:257–272.

Hajhashemi V, Ghafghazi T, Balali M, Ahmadi A, Taher M, Rajabi, et al. Toxicological studies on an anticancer drug (HESA-A) with marine origin. Med J Islam Acad Sci 2001;14:145–149.